Phase II study of the multitargeted antifolate LY231514 (ALIMTA(TM), MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

K. D. Miller, J. Picus, C. Blanke, W. John, J. Clark, L. N. Shulman, D. Thornton, E. Rowinsky, P. J. Loehrer

Research output: Contribution to journalArticlepeer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of the multitargeted antifolate LY231514 (ALIMTA(TM), MTA, pemetrexed disodium) in patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences